Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $30.6 million.

  • Mimedx's Goodwill & Intangibles fell 17.62% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year decrease of 17.62%. This contributed to the annual value of $31.1 million for FY2024, which is 2578.75% up from last year.
  • Mimedx's Goodwill & Intangibles amounted to $30.6 million in Q3 2025, which was down 17.62% from $31.5 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Goodwill & Intangibles registered a high of $32.0 million during Q1 2024, and its lowest value of $24.7 million during Q4 2023.
  • Over the past 5 years, Mimedx's median Goodwill & Intangibles value was $25.7 million (recorded in 2023), while the average stood at $27.4 million.
  • As far as peak fluctuations go, Mimedx's Goodwill & Intangibles tumbled by 603.48% in 2021, and later surged by 2592.18% in 2024.
  • Over the past 5 years, Mimedx's Goodwill & Intangibles (Quarter) stood at $24.8 million in 2021, then increased by 1.89% to $25.3 million in 2022, then fell by 2.35% to $24.7 million in 2023, then grew by 25.79% to $31.1 million in 2024, then dropped by 1.54% to $30.6 million in 2025.
  • Its Goodwill & Intangibles was $30.6 million in Q3 2025, compared to $31.5 million in Q2 2025 and $30.5 million in Q1 2025.